Adrian Kolodzik

发表

In silico Design, Synthesis, and Screening of Novel Deoxyhypusine Synthase Inhibitors Targeting HIV‐1 Replication

J. Hauber, M. Rarey, C. Meier, 2014, ChemMedChem.

Rational Drug Design—Screening and Synthesis of Potential Deoxyhypusine Synthase Inhibitors Targeting HIV-1 Replication

J. Hauber, M. Rarey, C. Meier, 2010 .

Computer Processing of Chemical Structure Information

Matthias Rarey, Thomas Engel, Oliver Sacher, 2018, Chemoinformatics.

Structure‐Based Virtual Screening

Matthias Rarey, Adrian Kolodzik, Nadine Schneider, 2018 .

Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias

J. Hauber, M. Rarey, T. Brümmendorf, 2012, Investigational New Drugs.

Linker‐Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI‐1493 Suppress HIV‐1 Replication

J. Hauber, M. Rarey, J. van Lunzen, 2016, Archiv der Pharmazie.

NAOMI: On the Almost Trivial Task of Reading Molecules from Different File formats

Matthias Rarey, Sascha Urbaczek, Tobias Lippert, 2011, J. Chem. Inf. Model..

Unique Ring Families: A Chemically Meaningful Description of Molecular Ring Topologies

Matthias Rarey, Sascha Urbaczek, Adrian Kolodzik, 2012, J. Chem. Inf. Model..

Mycobacterium tuberculosis Rv0899 adopts a mixed α / β structure and does not form a transmembrane β -barrel

F. Marassi, P. Teriete, Houhui Song, 2010 .

PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1B.

D. Ullmann, P. Mracek, H. Nasiri, 2017, MedChemComm.

Mycobacterium tuberculosis Rv0899 adopts a mixed alpha/beta-structure and does not form a transmembrane beta-barrel.

M. Niederweis, F. Marassi, P. Teriete, 2010, Biochemistry.

The Valence State Combination Model: A Generic Framework for Handling Tautomers and Protonation States

Matthias Rarey, Sascha Urbaczek, Adrian Kolodzik, 2014, J. Chem. Inf. Model..